Find Funding Opportunities

 COVID-19 Funding Notices | Approved Initiative Concepts | Research Opportunity Announcements

All NINDS-related notices of funding opportunities (NOFOs), request for applications (RFAs), program announcements (PAs), and other NIH Guide announcements are listed. Search the Closed Opportunities tab to find expired opportunities. Search the Notices tab to find all Notices.

Learn more about award types and program directors and managers.

NINDS has a number of open positions for researchers and clinicians to contribute to exciting neuroscience programs - APPLY NOW!

For more focused results add quotes to indicate parameters. Example format: "search term".

Notice of Change to Award Budget for RFA-NS-21-029, "HEAL Initiative: Planning Studies for Initial Analgesic Development [Small Molecules and Biologics] (R61 Clinical Trial Not Allowed)
Expiration Date: Friday, January 1, 2027 NOFO Number: NOT-NS-23-105 Release Date: Wednesday, August 9, 2023 Notice Type: NOT
The purpose of this notice is to inform applicants of a change to the Award Budget for RFA-NS-21-029 "HEAL Initiative: Planning Studies for Initial Analgesic Development [Small Molecules and Biologics] (R61 Clinical Trial Not Allowed). The Award Budget changes to the Notice of Funding Opportunity (NOFO) are shown below.
Notice of Early Termination of PAR-21-057 "Analytical Validation of a Candidate Biomarker for Neurological or Neuromuscular Disorders (U44 Clinical Trial Optional)"
Expiration Date: Friday, January 1, 2027 NOFO Number: NOT-NS-23-103 Release Date: Tuesday, August 8, 2023 Notice Type: NOT
The purpose of this notice is to inform applicants of the early termination of PAR-21-057 "Analytical Validation of a Candidate Biomarker for Neurological or Neuromuscular Disorders (U44 Clinical Trial Optional)". The September 7, 2023 AIDS date has been cancelled.
Notice of Early Termination of PAR-21-059 "Clinical Validation of a Candidate Biomarker for Neurological or Neuromuscular Disorders (U44 Clinical Trial Optional)"
Expiration Date: Friday, January 1, 2027 NOFO Number: NOT-NS-23-104 Release Date: Tuesday, August 8, 2023 Notice Type: NOT
The purpose of this notice is to inform applicants of the early termination of PAR-21-059 "Clinical Validation of a Candidate Biomarker for Neurological or Neuromuscular Disorders (U44 Clinical Trial Optional)". The September 7, 2023 AIDS date has been cancelled.
Notice of Change to Extend Last Receipt Date for NINDS Innovation Grants to Nurture Initial Translational Efforts (IGNITE) PAR-21-122, PAR-21-123 and PAR-21-124 (R61/R33 Clinical Trial Not Allowed)
Expiration Date: Friday, January 1, 2027 NOFO Number: NOT-NS-23-095 Release Date: Thursday, August 3, 2023 Notice Type: NOT
Extending these NOFOs by one receipt date.
Notice of NINDS Participation in PAR-23-109 "NIH Medical Scientist Partnership Program (FM1 Clinical Trial Not Allowed)"
Expiration Date: Friday, January 1, 2027 NOFO Number: NOT-NS-23-102 Release Date: Thursday, August 3, 2023 Notice Type: NOT
The purpose of this notice is to inform applicants of NINDS' participation in PAR-23-109 "NIH Medical Scientist Partnership Program (FM1 Clinical Trial Not Allowed)".
Notice of Information: High-Priority Principles of Rigorous Research for the Final Receipt Date of NINDS Materials to Enhance Training in Experimental Rigor (METER) Funding Opportunity
Expiration Date: Friday, January 1, 2027 NOFO Number: NOT-NS-23-101 Release Date: Friday, July 28, 2023 Notice Type: NOT
TheOffice of Research Quality at the National Institute of Neurological Disorders and Stroke (NINDS) is issuing this notice to inform the extramural research community about principles of rigorous biomedical research that have not yet been selected for development into educational units by previous awardees of theMaterials to Enhance Training in Experimental Rigor (METER) (UE5 Clinical Trial Not Allowed) funding opportunity. ?One receipt date remains for METER: October 10, 2023.
Notice of Change to Extend Last Receipt Date for PAR-21-032: "NINDS Ruth L. Kirschstein National Research Service Award (NRSA) for Training of Postdoctoral Fellows (F32 Clinical Trial Not Allowed)"
Expiration Date: Friday, January 1, 2027 NOFO Number: NOT-NS-23-098 Release Date: Thursday, July 27, 2023 Notice Type: NOT
Adding a receipt date.
Notice of Special Interest (NOSI): Small Business Initiatives for Innovative tools and Technologies for Improving Outcomes for Maternal Health
Expiration Date: Sunday, September 6, 2026 NOFO Number: NOT-EB-23-005 Release Date: Wednesday, July 26, 2023 Notice Type: Notice of Special Interest
The purpose of this trans-NIH Notice of Special Interest (NOSI) is to inform potential applicants that the National Institute of Biomedical Imaging and Bioengineering and participating Institutes and Centers (ICs) invite SBIR/STTR applications to develop technologies or tools to quantitatively predict or indicate an increased risk for maternal morbidity and mortality (MMM). This NOSI is part of the Implementing a Maternal health and PRegnancy Outcomes Vision for Everyone (IMPROVE) initiative, which supports research to reduce preventable causes of maternal deaths and improve health for women before, during, and after delivery.
Request for Information (RFI) on Opportunities for Biomarker Research in Amyotrophic Lateral Sclerosis (ALS)
Expiration Date: Friday, January 1, 2027 NOFO Number: NOT-NS-23-097 Release Date: Friday, July 21, 2023 Notice Type: NOT
TBD
Notice of Intent to Publish a Funding Opportunity Announcement for Diagnostic Centers of Excellence (U01 - Clinical Trial Not Allowed)
Expiration Date: Friday, January 1, 2027 NOFO Number: NOT-NS-23-096 Release Date: Monday, July 17, 2023 Notice Type: NOT
TBD
Export to:
CSV
JSON
XLSX
RSS
A maximum of 400 records can be exported.